Home » Stocks » PRFX

PainReform Ltd. (PRFX)

Stock Price: $5.40 USD 0.10 (1.89%)
Updated Mar 8, 2021 1:12 PM EST - Market open
Market Cap 46.42M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 8.76M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 8
Last Price $5.40
Previous Close $5.30
Change ($) 0.10
Change (%) 1.89%
Day's Open 5.29
Day's Range 5.25 - 5.69
Day's Volume 78,373
52-Week Range 3.82 - 7.85

News

Hide News
GlobeNewsWire - 4 hours ago

HERZLIYA, Israel, March 08, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulat...

GlobeNewsWire - 2 months ago

HERZLIYA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulati...

GlobeNewsWire - 2 months ago

HERZLIYA, Israel, Jan. 06, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulati...

About PRFX

PainReform, a clinical stage specialty pharmaceutical company, engages in the development of products for the treatment of pain in Israel. It develops PRF-110, a product based on local anesthetic ropivacaine, which completed Phase II clinical study in hernia repair. The company was founded in 2007 and is headquartered in Herzeliya, Israel.

Industry
Drug Manufacturers-Specialty & Generic
IPO Date
Sep 1, 2020
Stock Exchange
NASDAQ
Ticker Symbol
PRFX
Full Company Profile

Financial Performance

Financial Statements